Aborted Cardiac Arrest in LQT2 Related to Novel KCNH2 (hERG) Variant Identified in One Lithuanian Family.
Neringa BileišienėJūratė BarysienėVioleta MikštienėEglė PreikšaitienėGermanas MarinskisMonika KezeviciuteAlgirdas UtkusAudrius AidietisPublished in: Medicina (Kaunas, Lithuania) (2021)
Congenital long QT syndrome (LQTS) is a hereditary ion channelopathy associated with ventricular arrhythmia and sudden cardiac death starting from young age due to prolonged cardiac repolarization, which is represented by QT interval changes in electrocardiogram (ECG). Mutations in human ether-à-go-go related gene (KCNH2 (7q36.1), formerly named hERG) are responsible for Long QT syndrome type 2 (LQT2). LQT2 is the second most common type of LQTS. A resuscitated 31-year-old male with the diagnosis of LQT2 and his family are described. Sequencing analysis of their genomic DNA was performed. Amino acid alteration p.(Ser631Pro) in KCNH2 gene was found. This variant had not been previously described in literature, and it was found in three nuclear family members with different clinical course of the disease. Better understanding of genetic alterations and genotype-phenotype correlations aids in risk stratification and more effective management of these patients, especially when employing a trigger-specific approach to risk-assessment and individually tailored therapy.
Keyphrases
- cardiac arrest
- copy number
- drug induced
- risk assessment
- genome wide
- cardiopulmonary resuscitation
- end stage renal disease
- amino acid
- left ventricular
- ejection fraction
- newly diagnosed
- endothelial cells
- heart failure
- chronic kidney disease
- case report
- genome wide identification
- prognostic factors
- heart rate variability
- single cell
- catheter ablation
- heavy metals
- stem cells
- bone marrow
- anti inflammatory
- atrial fibrillation
- middle aged
- transcription factor
- human health
- pluripotent stem cells